132 related articles for article (PubMed ID: 15116325)
1. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).
Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325
[TBL] [Abstract][Full Text] [Related]
2. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.
George TI; Wrede JE; Bangs CD; Cherry AM; Warnke RA; Arber DA
J Mol Diagn; 2005 Aug; 7(3):346-51. PubMed ID: 16049306
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
[TBL] [Abstract][Full Text] [Related]
4. PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.
Poppe B; De Paepe P; Michaux L; Dastugue N; Bastard C; Herens C; Moreau E; Cavazzini F; Yigit N; Van Limbergen H; De Paepe A; Praet M; De Wolf-Peeters C; Wlodarska I; Speleman F
Genes Chromosomes Cancer; 2005 Oct; 44(2):218-23. PubMed ID: 15942942
[TBL] [Abstract][Full Text] [Related]
5. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
Iida S; Rao PH; Nallasivam P; Hibshoosh H; Butler M; Louie DC; Dyomin V; Ohno H; Chaganti RS; Dalla-Favera R
Blood; 1996 Dec; 88(11):4110-7. PubMed ID: 8943844
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).
Iida S; Rao PH; Ueda R; Chaganti RS; Dalla-Favera R
Leuk Lymphoma; 1999 Jun; 34(1-2):25-33. PubMed ID: 10350329
[TBL] [Abstract][Full Text] [Related]
7. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
[TBL] [Abstract][Full Text] [Related]
8. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
10. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
Schop RF; Kuehl WM; Van Wier SA; Ahmann GJ; Price-Troska T; Bailey RJ; Jalal SM; Qi Y; Kyle RA; Greipp PR; Fonseca R
Blood; 2002 Oct; 100(8):2996-3001. PubMed ID: 12351413
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
Busslinger M; Klix N; Pfeffer P; Graninger PG; Kozmik Z
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6129-34. PubMed ID: 8650231
[TBL] [Abstract][Full Text] [Related]
12. Rarity of IgH translocations in Waldenström macroglobulinemia.
Ackroyd S; O'Connor SJ; Owen RG
Cancer Genet Cytogenet; 2005 Nov; 163(1):77-80. PubMed ID: 16271961
[TBL] [Abstract][Full Text] [Related]
13. Genetics and cytogenetics of Waldenstrom's macroglobulinemia.
Schop RF; Fonseca R
Semin Oncol; 2003 Apr; 30(2):142-5. PubMed ID: 12720124
[TBL] [Abstract][Full Text] [Related]
14. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.
Renné C; Martín-Subero JI; Hansmann ML; Siebert R
J Mol Diagn; 2005 Aug; 7(3):352-6. PubMed ID: 16049307
[TBL] [Abstract][Full Text] [Related]
16. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Ohno H; Ueda C; Akasaka T
Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
[TBL] [Abstract][Full Text] [Related]
17. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.
Baró C; Salido M; Domingo A; Granada I; Colomo L; Serrano S; Solé F
Haematologica; 2006 Sep; 91(9):1289-91. PubMed ID: 16956840
[TBL] [Abstract][Full Text] [Related]
18. t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.
Ohno H; Takeoka K; Kishimori C; Nakagawa M; Fukutsuka K; Maekawa F; Hayashida M; Akasaka T; Sumiyoshi S
J Clin Exp Hematop; 2021 Dec; 61(4):216-220. PubMed ID: 34707037
[TBL] [Abstract][Full Text] [Related]
19. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
20. Characterization of IGH rearrangements in non-Hodgkin's B-cell lymphomas by fluorescence in situ hybridization.
Bernicot I; Douet-Guilbert N; Le Bris MJ; Morice P; Abgrall JF; Berthou C; Morel F; De Braekeleer M
Anticancer Res; 2005; 25(5):3179-82. PubMed ID: 16101124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
